Intellectual Property And Biotechnology: Biological Inventions
by Matthew Rimmer /
2008 / English / PDF
1.2 MB Download
This book documents and evaluates the dramatic expansion of
intellectual property law to accommodate various forms of
biotechnology from micro-organisms, plants, and animals to human
genes and stem cells. It makes a unique theoretical contribution to
the controversial public debate over the commercialization of
biological inventions. The author also considers the contradictions
between the Supreme Court of Canada rulings in respect of the
Harvard oncomouse, and genetically modified canola. He explores
law, policy, and practice in both Australia and New Zealand in
respect to gene patents and non-coding DNA. This study charts the
rebellion against the European Union Biotechnology Directive -
particularly in respect of Myriad Genetics' BRCA1 and BRCA2
patents, and stem cell patent applications. The book also considers
whether patent law will accommodate frontier technologies - such as
bioinformatics, haplotype mapping, proteomics, pharmacogenomics,
and nanotechnology. Intellectual Property and Biotechnology will be
of prime interest to lawyers and patent attorneys, scientists and
researchers, business managers and technology transfer specialists.
This book documents and evaluates the dramatic expansion of
intellectual property law to accommodate various forms of
biotechnology from micro-organisms, plants, and animals to human
genes and stem cells. It makes a unique theoretical contribution to
the controversial public debate over the commercialization of
biological inventions. The author also considers the contradictions
between the Supreme Court of Canada rulings in respect of the
Harvard oncomouse, and genetically modified canola. He explores
law, policy, and practice in both Australia and New Zealand in
respect to gene patents and non-coding DNA. This study charts the
rebellion against the European Union Biotechnology Directive -
particularly in respect of Myriad Genetics' BRCA1 and BRCA2
patents, and stem cell patent applications. The book also considers
whether patent law will accommodate frontier technologies - such as
bioinformatics, haplotype mapping, proteomics, pharmacogenomics,
and nanotechnology. Intellectual Property and Biotechnology will be
of prime interest to lawyers and patent attorneys, scientists and
researchers, business managers and technology transfer specialists.